Advantageous salts of μ-opiate receptor peptides
US8940704B2 · kind B2 · utility
6Cited by
3References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 17, 2013 |
| Grant date | Jan 27, 2015 |
| Priority date | — |
| Expiry date | Oct 17, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their crystal structure, stability, solubility, lack of impurities and/or the ability to be produced, with these advantageous properties, in amounts sufficient for the production of therapeutic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.